Details for New Drug Application (NDA): 211915
✉ Email this page to a colleague
The generic ingredient in SEVELAMER CARBONATE is sevelamer carbonate. There are thirty-two drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the sevelamer carbonate profile page.
Summary for 211915
Tradename: | SEVELAMER CARBONATE |
Applicant: | Strides Pharma |
Ingredient: | sevelamer carbonate |
Patents: | 0 |
Pharmacology for NDA: 211915
Mechanism of Action | Phosphate Chelating Activity |
Suppliers and Packaging for NDA: 211915
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SEVELAMER CARBONATE | sevelamer carbonate | TABLET;ORAL | 211915 | ANDA | Strides Pharma Science Limited | 64380-872 | 64380-872-04 | 30 TABLET in 1 BOTTLE (64380-872-04) |
SEVELAMER CARBONATE | sevelamer carbonate | TABLET;ORAL | 211915 | ANDA | Strides Pharma Science Limited | 64380-872 | 64380-872-67 | 270 TABLET in 1 BOTTLE (64380-872-67) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 800MG | ||||
Approval Date: | May 9, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription